Topic: cancer

Why Public Health? Darrell Gray, II

May 2014 — In our video series “Why Public Health?” we ask Harvard School of Public Health students and alumni to talk about what drew them to the field. Darrell Gray, II, MD, MPH ’14, is determined to reduce the incidence of colorectal…

Vasectomy may increase risk of aggressive prostate cancer

For immediate release: Monday, July 7, 2014 Boston, MA -- Vasectomy was associated with a small increased risk of prostate cancer, and a stronger risk for advanced or lethal prostate cancer, according to a new study from Harvard School of Public Health…

Red meat may raise young women’s breast cancer risk

New research from Harvard School of Public Health (HSPH) finds a link between high consumption of red meat and breast cancer in young women. Compared with women who had one serving of red meat a week, those who ate 1.5 servings a…

Screening childhood cancer survivors for heart problems

Simulations find improved outcomes but suggest less frequent screening may be as beneficial For immediate release: May 19, 2014 Boston, MA — One of the first studies to analyze the effectiveness of screening survivors of childhood cancer for early signs of impending…

Delaying hormone therapy after prostate cancer relapse

Men whose prostate cancer returns in blood tests after initial treatment may be able to delay hormone therapy aimed at stopping the disease’s progression and thus avoid significant side effects, according to a new Harvard School of Public Health (HSPH) study. The…

Where's the salt?

[ Spring 2014 ] People across the globe are consuming far more sodium than is healthy, according to a new study led by researchers at Harvard School of Public Health and the University of Cambridge. In 181 of 187 countries (constituting 99.2% of the…

New molecule links asthma, cancer

A newly discovered molecule may play a role in controlling both asthma-induced airway muscle thickening and tumor growth—and manipulating it may lead to new asthma and cancer drugs, according to a new study led by researchers at Harvard School of Public Health…

Affordable cancer treatments are few, lack research funding

Research is lacking on potential low-cost cancer treatments because the drugs involved won’t provide big profits for pharmaceutical companies, according to an April 23, 2014 ProPublica article. The article describes the experience of Michael Retsky of Harvard School of Public Health (HSPH), who…